Jon E. Angell

Array ( [id] => 5667608 [patent_doc_number] => 20060172958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Phospholipid scramblase 3' [patent_app_type] => utility [patent_app_number] => 10/548329 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22674 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172958.pdf [firstpage_image] =>[orig_patent_app_number] => 10548329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333189 [patent_doc_number] => 20040131600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Method of preventing adhesions by apoptosis of adhesion peritoneal cells' [patent_app_type] => new [patent_app_number] => 10/471899 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6712 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131600.pdf [firstpage_image] =>[orig_patent_app_number] => 10471899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7033706 [patent_doc_number] => 20050032216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Vector' [patent_app_type] => utility [patent_app_number] => 10/787881 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21293 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032216.pdf [firstpage_image] =>[orig_patent_app_number] => 10787881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 910367 [patent_doc_number] => 07329649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-12 [patent_title] => 'Combinatorial methods for inducing cancer cell death' [patent_app_type] => utility [patent_app_number] => 10/783571 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 30 [patent_no_of_words] => 20705 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/329/07329649.pdf [firstpage_image] =>[orig_patent_app_number] => 10783571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835362 [patent_doc_number] => 20060247193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Regulation of gene expression by dna interference' [patent_app_type] => utility [patent_app_number] => 10/544761 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 30530 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247193.pdf [firstpage_image] =>[orig_patent_app_number] => 10544761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088929 [patent_doc_number] => 20050009042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Oligonucleotides which inhibit expression of the OB-RGRP protein and method for detecting compounds which modify the interaction between proteins of the OB-RGRP family and the leptin receptor' [patent_app_type] => utility [patent_app_number] => 10/774721 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14359 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009042.pdf [firstpage_image] =>[orig_patent_app_number] => 10774721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230088 [patent_doc_number] => 20040156830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Vector and pharmaceutical composition containing cell death inducing gene' [patent_app_type] => new [patent_app_number] => 10/769856 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5249 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156830.pdf [firstpage_image] =>[orig_patent_app_number] => 10769856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006395 [patent_doc_number] => 08084598 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-12-27 [patent_title] => 'Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/707980 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 39 [patent_no_of_words] => 31031 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084598.pdf [firstpage_image] =>[orig_patent_app_number] => 10707980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7296325 [patent_doc_number] => 20040214320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Mammalian gamete and embryo culture media supplement and method of using same' [patent_app_type] => new [patent_app_number] => 10/764821 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5994 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214320.pdf [firstpage_image] =>[orig_patent_app_number] => 10764821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405310 [patent_doc_number] => 20040175740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Method for treatment of insulin resistance in obesity and diabetes' [patent_app_type] => new [patent_app_number] => 10/764712 [patent_app_country] => US [patent_app_date] => 2004-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19780 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175740.pdf [firstpage_image] =>[orig_patent_app_number] => 10764712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7348664 [patent_doc_number] => 20040248299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'RNA interference' [patent_app_type] => new [patent_app_number] => 10/745395 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 31082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248299.pdf [firstpage_image] =>[orig_patent_app_number] => 10745395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169073 [patent_doc_number] => 20040077573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Method for regulating the activity of an expression product of a gene transferred into living body' [patent_app_type] => new [patent_app_number] => 10/432305 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6838 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077573.pdf [firstpage_image] =>[orig_patent_app_number] => 10432305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290890 [patent_doc_number] => 20040110716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Cancer gene therapy based on translational control of a suicide gene' [patent_app_type] => new [patent_app_number] => 10/718163 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11536 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110716.pdf [firstpage_image] =>[orig_patent_app_number] => 10718163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453062 [patent_doc_number] => 20040067904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Gene therapy for prostate cancer: sensibilization of cells to dna damaging drugs and radiation' [patent_app_type] => new [patent_app_number] => 10/450411 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10029 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067904.pdf [firstpage_image] =>[orig_patent_app_number] => 10450411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001440 [patent_doc_number] => 09045518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Amino-LNA, thio-LNA and alpha-L-oxy-LN' [patent_app_type] => utility [patent_app_number] => 10/535472 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 18987 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10535472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468675 [patent_doc_number] => 20040096460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus' [patent_app_type] => new [patent_app_number] => 10/702755 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17978 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096460.pdf [firstpage_image] =>[orig_patent_app_number] => 10702755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7413079 [patent_doc_number] => 20040106773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Human tuberoinfundibular peptide of 39 residues' [patent_app_type] => new [patent_app_number] => 10/399602 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15061 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106773.pdf [firstpage_image] =>[orig_patent_app_number] => 10399602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040402 [patent_doc_number] => 20050159374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => '2\'-Substituted nucleosides and oligonucleotide derivatives' [patent_app_type] => utility [patent_app_number] => 10/696488 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22104 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159374.pdf [firstpage_image] =>[orig_patent_app_number] => 10696488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289339 [patent_doc_number] => 20040110218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes' [patent_app_type] => new [patent_app_number] => 10/696259 [patent_app_country] => US [patent_app_date] => 2003-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110218.pdf [firstpage_image] =>[orig_patent_app_number] => 10696259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276313 [patent_doc_number] => 20040235764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Methods of inhibiting expression of a target gene in mammalian cells' [patent_app_type] => new [patent_app_number] => 10/469447 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8532 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235764.pdf [firstpage_image] =>[orig_patent_app_number] => 10469447 [rel_patent_id] =>[rel_patent_doc_number] =>)